ANGELA GRAHAM: Open Payments
NPI 1598327330 · PEARISBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 28 payments from 15 companies in 2025. Trend: 2023 $168 · 2024 $584 · 2025 $736
Food & beverage: $720Education: $16
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $128 |
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| ABBVIE INC. | 3 | $74 |
| PFIZER INC. | 3 | $67 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| Janssen Biotech, Inc. | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Legend Biotech USA Inc. | 2 | $37 |
| Iovance Biotherapeutics, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $30 |
Products named: Jakafi, PLUVICTO, ZEJULA, TECVAYLI, EPKINLY, INLYTA, CARVYKTI, Amtagvi.
Industry payments across VA — which companies pay providers there.
